Long-Term HIV Management: Switch to DTG/FTC Is Safe, Noninferior to 3-Drug ART
DTG/FTC was effective for long-term HIV management with a good safety profile, suggesting it may be a viable alternative option to 3-drug ART regimens.
Related Articles
French study explores role of chest x-rays in antibiotic prescribing for pneumonia
Researchers found that more than two thirds of patients with negative chest x-rays received antibiotics.
CARB-X to partner with Clinton Health Access Initiative on gonorrhea-focused interventions
The partnership will evaluate the clinical need and address market barriers for diagnostic, therapeutic, and preventive interventions for gonorrhea in low-resource countries.
Pediatric hospital beds lost due to impact of COVID-19 pandemic
The number of hospitals with at least 1 non-neonatal pediatric admission declined by 374 across the country.
Texas reports its first local dengue case of the year
The case was reported in a resident of Cameron County, located on the state’s southern tip.
Study: No unexpected COVID vaccine safety concerns in kids
Postvaccination reactions were reported for 46.7% of children.
Sluggish gas exchange in the lungs may be involved in long-COVID brain fog
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 Lower rates of gas exchange in the lungs may contribute to impaired cognitive function (“brain fog”) tied to long COVID,…
Canadian probe into teen’s critical H5N1 infection finds no clear source
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 As a Canadian teen remains in critical care with an H5N1 avian flu infection in a British Columbia hospital, health…
Survey: Doctors rank pertussis vaccine less important than those for other respiratory diseases
They did recognize that adults with weakened immune systems and chronic respiratory illnesses are at elevated risk for severe illness.
In vitro and in vivo characterization of a novel West Nile virus lineage 2 strain
npj Viruses – In vitro and in vivo characterization of a novel West Nile virus lineage 2 strain
HHS ASPR announces new investments to support essential medicine supply chain
The investments, worth $44 million, are geared toward boosting on-shore capacity and production.